TABLE 2.
Summary of Coinfection with SARS-CoV-2 by Pathogen (N = 19,199)
Number of Participants With Pathogen | SARS-CoV-2 Positive, N = 1466 | SARS-CoV-2 Negative, N = 17,733 | P * | |
---|---|---|---|---|
Rhino/enterovirus | 6285 | 230 (15.69%) | 6055 (34.15%) | <0.001 |
RSV | 2473 | 45 (3.07%) | 2428 (13.69%) | <0.001 |
Influenza A | 193 | 5 (0.34%) | 188 (1.06%) | 0.008 |
Influenza B | 6 | 2 (0.14%) | 4 (0.02%) | 0.071 |
Parainfluenza 1 | 11 | 0 (0.00%) | 11 (0.06%) | >0.999 |
Parainfluenza 2 | 284 | 13 (0.89%) | 271 (1.53%) | 0.051 |
Parainfluenza 3 | 1,071 | 26 (1.77%) | 1045 (5.89%) | <0.001 |
Parainfluenza 4 | 210 | 7 (0.48%) | 203 (1.14%) | 0.018 |
Coronavirus 229E | 51 | 2 (0.14%) | 49 (0.28%) | 0.434 |
Coronavirus HKU1 | 11 | 1 (0.07%) | 10 (0.06%) | 0.583 |
Coronavirus NL63 | 187 | 4 (0.27%) | 183 (1.03%) | 0.004 |
Coronavirus OC43 | 371 | 6 (0.41%) | 365 (2.06%) | <0.001 |
HMPV | 1110 | 24 (1.64%) | 1086 (6.12%) | <0.001 |
Mycoplasma pneumoniae | 2 | 0 (0.00%) | 2 (0.01%) | >0.999 |
Adenovirus | 1277 | 62 (4.23%) | 1215 (6.85%) | <0.001 |
Chi-square or Fisher’s tests for independence between SARS-CoV-2 detection and detection of the other pathogen.
HMPV indicates human metapneumovirus; RSV, respiratory syncytial virus.